TheProfitWatch

RNAC - Cartesian Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.44 0.26 (2.75%) --- --- --- 0.09 (0.99%) 0.23 (2.43%) --- 0.09 (0.99%)

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
0.51
Diluted EPS:
0.5
Basic P/E:
19.0196
Diluted P/E:
19.4
RSI(14) 1m:
57.5
VWAP:
9.68
RVol:
0.6967

Events

Period Kind Movement Occurred At
1m Price decrease 1m 9.76 -0.17 (-1.66%) Oct 15 10:20
1m Price decrease 1m 9.58 -0.16 (-1.64%) Oct 15 09:41

Related News